VTYX insider trading
NasdaqGS HealthcareVentyx Biosciences, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for Crohn's disease. It is also developing Tamuzimod, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor that is in Phase 2a trial for patients with early Parkinson's disease and is in Phase 2 trial for patients with obesity and additional risk factors for cardiovascular disease. Ventyx Biosciences, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Company website: ventyxbio.com
VTYX insider activity at a glance
FilingIQ has scored 341 insider transactions for VTYX since Oct 25, 2021. The most recent filing in our index is dated Mar 4, 2026.
Across the full history, 6 open-market purchases
and 178 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on VTYX insider trades is 57.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest VTYX Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading VTYX
Frequently asked
- How many insider trades does FilingIQ track for VTYX?
- FilingIQ tracks 341 Form 4 insider transactions for VTYX (Ventyx Biosciences, Inc.), covering filings from Oct 25, 2021 onwards. 62 of those were filed in the last 90 days.
- Are VTYX insiders net buyers or net sellers?
- Across the full Form 4 history for VTYX, 6 transactions (2%) were open-market purchases and 178 (52%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VTYX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is VTYX in?
- Ventyx Biosciences, Inc. (VTYX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.00B.
Methodology & sources
Every VTYX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.